Aspergillus oryzae produces compounds inhibiting cholesterol biosynthesis downstream of dihydrolanosterol

FEMS Microbiology Letters

Volumn 242, Issue 1, 2005, Pages 155-159

  Hajjaj, Hassan ^a   Duboc, Philippe ^a   Fay, Laurent B ^a   Zbinden, Irène ^a   Macé, Katherine ^a   Niederberger, Peter ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Aspergillus oryzae; Cholesterol synthesis inhibition; Dihydrolanosterol; Fermentation; Lathosterol; Mevalonate; Sterol analogues

Indexed keywords

ACETIC ACID; DIHYDROLANOSTEROL; LATHOSTEROL; MEVALONIC ACID;

ARTICLE; ASPERGILLUS ORYZAE; CHOLESTEROL SYNTHESIS; CULTURE MEDIUM; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER CELL; NONHUMAN; PRIORITY JOURNAL;

ASPERGILLUS ORYZAE; CELLS, CULTURED; CHOLESTEROL; CULTURE MEDIA; ENZYME INHIBITORS; HEPATOCYTES; HUMANS; LANOSTEROL;

ASPERGILLUS; ASPERGILLUS ORYZAE;

EID: 11144304156     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.11.001     Document Type: Article

References (23)

1. M. Manzoni, and M. Rollini Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs Appl. Microbiol. Biotechnol. 58 2002 555 564
2. J.C. LaRosa, J. He, and S. Vupputuri Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials JAMA 282 1999 2340 2346
3. A.A. Shindia Mevinolin production by some fungi Folia Microbiol. (Praha) 42 1997 477 480
4. A.A. Shindia Studies on mevinolin production by some fungi Microbios 102 2000 53 61
5. A.W. Alberts, J. Chen, G. Kuron, V. Hunt, J. Huff, C. Hoffman, J. Rothrock, M. Lopez, H. Joshua, E. Harris, A. Patchett, R. Monaghan, S. Currie, E. Stapley, G. Albers-Schonberg, O. Hensens, J. Hirshfield, K. Hoogsteen, J. Liesch, and J. Springer Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent Proc. Natl. Acad. Sci. USA 77 1980 3957 3961
6. L.R. Treiber, R.A. Reamer, C.S. Rooney, and H.G. Ramjit Origin of monacolin L from Aspergillus terreus cultures J. Antibiot. (Tokyo) 42 1989 30 36
7. M. Evans, and A. Rees The myotoxicity of statins Curr. Opin. Lipidol. 13 2002 415 420
8. K. Folkers, P. Langsjoen, R. Willis, P. Richardson, L.J. Xia, C.Q. Ye, and H. Tamagawa Lovastatin decreases coenzyme Q levels in humans Proc. Natl. Acad. Sci. USA 87 1990 8931 8934
9. G. Ghirlanda, A. Oradei, A. Manto, S. Lippa, L. Uccioli, S. Caputo, A.V. Greco, and G.P. Littarru Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study J. Clin. Pharmacol. 33 1993 226 229
10. M. Morisaki, Y. Sonoda, T. Makino, N. Ogihara, N. Ikekawa, and Y. Sato Inhibitory effect of 15-oxygenated sterols on cholesterol synthesis from 24,25-dihydrolanosterol J. Biochem. (Tokyo) 99 1986 597 600
11. P. van den Broek, A. Pittet, and H. Hajjaj Aflatoxin genes and the aflatoxigenic potential of Koji moulds Appl. Microbiol. Biotechnol. 57 2001 192 199
12. A.M. Pfeifer, K.E. Cole, D.T. Smoot, A. Weston, J.D. Groopman, P.G. Shields, J.M. Vignaud, M. Juillerat, M.M. Lipsky, and B.F. Trump Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens Proc. Natl. Acad. Sci. USA 90 1993 5123 5127
13. H. Hajjaj, P. Niederberger, and P. Duboc Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium Appl. Environ. Microbiol. 67 2001 2596 2602
14. Y. Sonoda, N. Obi, M. Onoda, Y. Sakakibara, and Y. Sato Effects of 32-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis from 24,25-dihydrolanosterol Chem. Pharm. Bull. (Tokyo) 40 1992 2796 2799
15. J.M. Trzaskos, S.S. Ko, R.L. Magolda, M.F. Favata, R.T. Fischer, S.H. Stam, P.R. Johnson, and J.L. Gaylor Substrate-based inhibitors of lanosterol 14 α-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties Biochemistry 34 1995 9670 9676
16. C.A. Jones, P.J. Sidebottom, R.J. Cannell, D. Noble, and B.A. Rudd The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. III J. Antibiot. (Tokyo) 45 1992 1492 1498
17. S.M. Mandala, R.A. Thornton, B.R. Frommer, S. Dreikorn, and M.B. Kurtz Viridiofungins, novel inhibitors of sphingolipid synthesis J. Antibiot. (Tokyo) 50 1997 339 343
18. H. Colin, G. Guiochon, and A. Siouffi Comparison of various systems for the separation of free sterols by high performance liquid chromatography Anal. Chem. 51 1979 1661 1666
19. I. Ikeda, A. Kawasaki, K. Samezima, and M. Sugano Antihypercholesterolemic activity of β-sitostanol in rabbits J. Nutr. Sci. Vitaminol. (Tokyo) 27 1981 243 251
20. W.H. Ling, and P.J. Jones Dietary phytosterols: a review of metabolism, benefits and side effects Life Sci. 57 1995 195 206
21. J.A. Weststrate, and G.W. Meijer Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects Eur. J. Clin. Nutr. 52 1998 334 343
22. F.J. Field, E. Born, and S.N. Mathur Effect of micellar β-sitosterol on cholesterol metabolism in CaCo-2 cells J. Lipid Res. 38 1997 348 360
23. 7- reductase in liver and mononuclear leukocytes J. Lipid Res. 39 1998 44 50